| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108611 Substituted thienopyrimidine kinase inhibitors |
| 05/08/2008 | US20080107761 Extracts of Caesalpinia crista, extracts of Psophocarpus tetragonolobus, phytic acid, and L- hydroxyproline and a pharmaceutically acceptable salt |
| 05/08/2008 | US20080107758 Mixture with alcohol, propellant and isopropyl myristate; antiinflammatory agents; clobetasol proprionate, fluocinonide, triamcinolone acetonide, fluocinolene acetonide; black cumin, black raspberry, red raspberry, pumpkin seed oil, chardonnay grape seed oil, carrot seed oil; skin disorders |
| 05/08/2008 | US20080107743 Enhancing ceramide synthesis; topical calcium glycerophosphate and a fatty acid source derived from an animal or a vegetable; inhibits dephosphorylation of spingosine-1-phosphate; enhances conversion of phosphatidyl choline to phosphocholine and of phosphocholine to sphingomyelin and to ceramide |
| 05/08/2008 | US20080107742 Alkalinizing agent, humectant, detergent, wetting agent, antibacterial agent, stabilizer, emulsifier, antifungal agent, colorants, moisturizer, thickening agent, preservative, filler, keratolytic agent; menthol, camphor counterirritants; granules, beads, microspheres, grit, pumice, polymer, sand, glass |
| 05/08/2008 | US20080107734 Healing powder and method of use thereof |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107717 Methods and materials including treating acne related applications |
| 05/08/2008 | US20080107703 Hydrogel For Medical Use |
| 05/08/2008 | US20080107699 Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
| 05/08/2008 | US20080107677 Culture filtrate concentrate from Basidiomycetes; Parkinson's disease; diabetes |
| 05/08/2008 | US20080107646 Administering phenylbutyric acid derivative and pharmaceutically acceptable carrier |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107622 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |
| 05/08/2008 | US20080107617 Surfactant-containing cosmetic, dermatological and pharmaceutical agents |
| 05/08/2008 | DE202008002263U1 Gesundheitsförderndes Mittel und dessen Verwendung Health-promoting agent and its use |
| 05/08/2008 | CA2667953A1 Enzyme inhibition using nanoparticles |
| 05/08/2008 | CA2667903A1 Composition for the treatment of skin conditions |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918287A2 LPA receptor agonists and antagonists and methods of use |
| 05/07/2008 | EP1917956A2 External preparation composition |
| 05/07/2008 | EP1917955A2 Performance enhanced cosmetic agent with purine and/or purine derivatives II |
| 05/07/2008 | EP1917273A2 Apoe mimetic agents |
| 05/07/2008 | EP1917072A2 Vitamin formulation |
| 05/07/2008 | EP1916911A2 Use of a symbiotic for the treatment of atopic dermatitis |
| 05/07/2008 | EP1644318B1 Method for synthesizing ceramide-type compounds |
| 05/07/2008 | EP1566386B1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP0956299B1 Peptide antagonists of dp transcription factors |
| 05/07/2008 | CN201055525Y Convenient label for corn |
| 05/07/2008 | CN101175723A 1,2-di(cyclic) substituted benzene compounds |
| 05/07/2008 | CN101175512A Medical composition for promotion of skin regeneration |
| 05/07/2008 | CN101175497A Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form |
| 05/07/2008 | CN101172150A Externally used medicament for treating beriberi |
| 05/07/2008 | CN101172142A Medicament for treating carbuncle, gangrene, turgescence toxin and skin ulcer, and method of producing the same |
| 05/07/2008 | CN101172129A Traditional Chinese medicine composition for treating hypodermal ecchymosis and method of preparing the same |
| 05/07/2008 | CN101172126A Traditional Chinese medicine composition for health care beauty treatment |
| 05/07/2008 | CN101172114A Application of sanitizer lanthanum nitrate for stopping sexual transmission of AIDS virus and venereal disease causal agent |
| 05/07/2008 | CN101172112A Compound with special property, composition containing the compound, preparing method and uses of the same |
| 05/07/2008 | CN101172103A Medicament for treating multiple diseases such as climacteric syndrome and osteoporosis of women |
| 05/07/2008 | CN101172100A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172099A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172097A Liniment for treating bromhidrosis and confecting method thereof |
| 05/07/2008 | CN101172091A Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same |
| 05/07/2008 | CN101171927A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386106C Medicine for treating acne and its preparation method |
| 05/07/2008 | CN100386091C Medicine for treating canker and preparing method |
| 05/07/2008 | CN100386090C Medical dust cloud agent or granular agent and its use |
| 05/07/2008 | CN100386074C Retinoic acid and the like oral formulation |
| 05/06/2008 | US7368575 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries |
| 05/06/2008 | US7368553 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368450 Sodium channel blockers |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368144 Removal of shell, pulp; grinding in presence of solvent; macerating, extraction. filtration |
| 05/06/2008 | US7368131 Method and composition for treating hypopigmentation of the hair and skin |
| 05/06/2008 | CA2609766A1 Product for the management of inflammations, pressure sores and/or oral sores (aphthas) as well as the use of such product |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 05/06/2008 | CA2322878C Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
| 05/02/2008 | WO2008052145A2 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 05/02/2008 | WO2008052143A2 Mixing device and output fluids of same |
| 05/02/2008 | WO2008051080A1 Skin cream comprising a combination of aloe vera and spermine |
| 05/02/2008 | WO2008050866A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050157A2 Ozonated oil formulations |
| 05/02/2008 | WO2008049402A2 Nail varnish remover for cosmetic and medical applications |
| 05/02/2008 | WO2008049401A2 Nail varnish for cosmetic and medical applications |
| 05/02/2008 | WO2008049227A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 05/02/2008 | WO2008011611A3 Compounds and compositions as itpkb inhibitors |
| 05/02/2008 | WO2007093975A3 Use of the pedf factor to induce cell regeneration |
| 05/02/2008 | CA2693383A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 05/02/2008 | CA2667536A1 Highly purified type a botulinum toxin preparation from infant botulism pathogen |
| 05/02/2008 | CA2648243A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 05/01/2008 | US20080103184 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103163 Nociceptine antagonists; hydrochloride salts of N-amidino-2-{[2-(4-chlorobenzoylamino)-6-methylquinazolin-4-yl]amino}cyclohexylamine, 1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one and N-(4-amino-2-methyl-6-quinolyl)-2-[(4-ethylphenoxy)methyl]benzamide |
| 05/01/2008 | US20080103162 Antipruritics |
| 05/01/2008 | US20080103150 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 05/01/2008 | US20080103139 3-Carbamoyl-2-Pyridone Derivative |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080102126 obtained by the reaction of aliphatic isocyanate prepolymers with polyols comprising tertiary nitrogen in water; wound contact material |
| 05/01/2008 | US20080102103 Dissolvable Film Composition |
| 05/01/2008 | US20080102090 Mixture with surfactant; therapy for muscular paralysis; greater intramuscular safety margin; selective action on inhibition of pain-related (nociceptive) nerve cell function |
| 05/01/2008 | US20080102064 Mixture comprising blood coagulation factor and serpin for use in prevention and treatment of blood disorders |
| 05/01/2008 | US20080102045 Sunscreens, ultraviolet radiation protective lotions, cosmetics; includes zinc oxide and/or titanium dioxide |
| 05/01/2008 | US20080102038 Clobetasol spray |
| 04/30/2008 | EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations |
| 04/30/2008 | EP1916247A1 Activator of peroxisome proliferator activated receptor |
| 04/30/2008 | EP1916241A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 04/30/2008 | EP1916020A2 Preventives and/or remedies for systemic lupus erythematosus containing anti-IL-6 receptor antibody as the active ingredient |
| 04/30/2008 | EP1915997A1 Agent for hair growth |